Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size.

Lowney JK, Frisella MM, Lairmore TC, Doherty GM.

Surgery. 1998 Dec;124(6):1043-8, discussion 1048-9.

PMID:
9854581
2.

Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.

House MG, Cameron JL, Lillemoe KD, Schulick RD, Choti MA, Hansel DE, Hruban RH, Maitra A, Yeo CJ.

J Gastrointest Surg. 2006 Jan;10(1):138-45.

PMID:
16368504
3.

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.

Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, et al.

Gastroenterology. 1995 Jun;108(6):1637-49.

PMID:
7768367
4.

A personal experience with pancreatic and duodenal neuroendocrine tumors.

Jordan PH Jr.

J Am Coll Surg. 1999 Nov;189(5):470-82.

PMID:
10549736
5.

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.

Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF, Vilgrain V, Belghiti J, Bernades P, Ruszniewski P.

Gut. 1998 Sep;43(3):422-7.

6.

Endocrine tumors of the duodenum. A study of 55 cases relative to clinicopathological features and hormone content.

Heymann MF, Hamy A, Triau S, Miraillé E, Toquet C, Chomarat H, Cohen C, Maitre F, Le Bodie MF.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1367-71.

PMID:
15362754
7.

Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

Gullo L, Migliori M, Falconi M, Pederzoli P, Bettini R, Casadei R, Delle Fave G, Corleto VD, Ceccarelli C, Santini D, Tomassetti P.

Am J Gastroenterol. 2003 Nov;98(11):2435-9.

PMID:
14638345
8.

Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.

Mutch MG, Frisella MM, DeBenedetti MK, Doherty GM, Norton JA, Wells SA Jr, Lairmore TC.

Surgery. 1997 Dec;122(6):1012-9; discussion 1019-20.

PMID:
9426414
9.

Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.

Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, Schlumberger M, Pocard M, Boige V, Miquel C, Baudin E.

Surgery. 2003 Apr;133(4):375-82.

PMID:
12717354
10.

Large and asymptomatic pancreatic islet cell tumor in a patient with multiple endocrine neoplasia type 1.

Sato M, Kihara M, Nishitani A, Murao K, Kobayashi S, Miyauchi A, Takahara J.

Endocrine. 2000 Dec;13(3):263-6.

PMID:
11216636
11.

Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).

Cadiot G, Vuagnat A, Doukhan I, Murat A, Bonnaud G, Delemer B, Thiéfin G, Beckers A, Veyrac M, Proye C, Ruszniewski P, Mignon M.

Gastroenterology. 1999 Feb;116(2):286-93.

PMID:
9922308
12.

Benign and malignant gastrinoma.

Stabile BE, Passaro E Jr.

Am J Surg. 1985 Jan;149(1):144-50.

PMID:
2857072
13.

[Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].

Kianmanesh R, O'toole D, Sauvanet A, Ruszniewski P, Belghiti J.

J Chir (Paris). 2005 May-Jun;142(3):132-49. Review. French.

PMID:
16142076
14.

Multiple endocrine syndrome type I. Clinical, laboratory findings, and management in five families.

Samaan NA, Ouais S, Ordonez NG, Choksi UA, Sellin RV, Hickey RC.

Cancer. 1989 Aug 1;64(3):741-52.

15.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
16.

Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome.

Botsios D, Vasiliadis K, Tsalis K, Iordanidis F, Megalopoulos A, Tsachalis T, Blouhos K, Betsis D.

J Gastrointestin Liver Dis. 2007 Sep;16(3):257-62.

17.

Surgical experience with functioning pancreatic neuroendocrine tumors.

Matthews BD, Smith TI, Kercher KW, Holder WD Jr, Heniford BT.

Am Surg. 2002 Aug;68(8):660-5; discussion 665-6.

PMID:
12206598
18.

Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors.

Hofer MD, Chang MC, Hirko KA, Rubin MA, Nosé V.

Mod Pathol. 2009 Jul;22(7):933-9. doi: 10.1038/modpathol.2009.50. Epub 2009 Apr 17.

19.

[Pathologic study with immunohistochemistry of 61 pancreatic endocrine tumors in 16 patients suffering from multiple endocrine neoplasia type I (MEN I). Review of the literature].

Heymann MF, Moreau A, Chetritt J, Murat A, Leborgne J, Le Neel JC, Visset J, Le Bodic MF.

Ann Pathol. 1996;16(3):167-73. Review. French.

PMID:
8766173
20.

The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.

Langstein HN, Norton JA, Chiang V, O'Dorisio TM, Maton PN, Marx SJ, Jensen RT.

Surgery. 1990 Dec;108(6):1109-15; discussion 1115-6.

PMID:
2174193

Supplemental Content

Support Center